Cambridge, Massachusetts, United States · On-site
Summary The Senior Clinical Trial Manager will lead the day-to-day activities in a clinical trial, and support the program strategy in a highly collaborative environment. The successful candidate will manage members of t…
Skills: Clinical Trial Management, CRO Oversight, Study Startup, Site Monitoring, GCP
Oslo, Norway · On-site
Summary At ARTBIO, we are looking for a structured and service-minded Office Coordinator to support our Oslo office. This is a part-time role (approx. 50–60%) based on-site in Oslo. You will play a key role in creating a…
Skills: Office Coordination, Facility Management, Event Planning, Onboarding/Offboarding, Vendor Management
Oslo, Norway · On-site
Summary The Associate Director, CMC Development provides scientific and cross-functional leadership for radiopharmaceutical development programs spanning discovery through First-in-Human readiness. The role integrates ra…
Skills: Radiochemistry, CMC Development, Analytical Development, GMP Principles, Clinical Manufacturing
Cambridge, Massachusetts, United States · Hybrid
Summary The Senior Director of Clinical Operations oversees all aspects of clinical trial execution, including start-up, monitoring, and close-out activities for all ARTBIO programs. This key role leads the clinical oper…
Skills: Clinical Trial Execution, CRO Management, Project Management, Good Clinical Practices, ICH Guidelines
Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.
The Senior Clinical Trial Manager leads day-to-day clinical trial activities, managing CROs, vendors, and clinical sites to ensure deliverables are met on time and within budget. They serve as the cross-functional lead for trial execution, overseeing data integrity, regulatory compliance, and risk mitigation.
Candidates must have a Bachelor's or Master's degree in Life Sciences or a related field with 5 to 8 years of clinical operations experience in a biotech or pharmaceutical company. Extensive experience in US clinical site management and oncology is required, along with strong knowledge of GCP, ICH, and FDA regulations.
Channeling Energy. Changing Lives. ARTBIO redefines cancer care by discovering and developing a new class of Alpha Radioligand Therapies (ARTs), powered by unique Pb-212 isotope technology and seamless supply. Our team works tirelessly to bring therapies that matter to patients who need them.
The unique ARTBIO approach selects the optimal alpha-precursor isotope (212Pb) and tumor-specific targets to create therapeutics with the potential for the highest efficacy and safety. The company's AlphaDirect™ technology, a first-of-its-kind 212Pb isolation method, enables a distributed manufacturing approach for the reliable production and delivery of ARTs. ARTBIO is advancing multiple pipeline programs, with lead program AB001 currently in first-in-human trials. The company is shaped by a long-standing scientific legacy with nearly a century of pioneering work in radiation therapy conducted at the University of Oslo and Norway’s Radium Hospital.
Cancer is relentless. So are we. We are driven by a desire to do better for cancer patients, lowering the burden of toleration and safety while at the same time raising the bar on clinical efficacy and duration. As an emerging, global biotech with locations in Boston, Basel, London, and Oslo, we take advantage of diverse scientific depth and insights, which makes ARTBIO a unique place to work.
ARTBIO is proud to be an equal opportunity workplace and is an affirmative action employer. We are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status. If you have a disability or special need that requires accommodation, please let us know.
If interested, please apply and send your CV to [email protected]. All inquiries are treated confidentially.
Channeling Energy. Changing Lives.
Cancer is relentless. So are we. ARTBIO redefines cancer care by discovering and developing a new class of Alpha Radioligand Therapies (ARTs), powered by unique Pb-212 isotope technology and seamless supply. Our team works tirelessly to bring therapies that matter to patients who need them.
Offices: Kendall Sq, c/o Alexandria LaunchLabs B200, Suite 001, Cambridge, Massachusetts 02139, US · Gaustadalléen 21, Oslo Science Park, Oslo, 0349, NO · Aeschengraben 9, Basel, BS 4051, CH · 77 New Cavendish Street, The Harley Building, London, England W1W 6XB, GB · 62 Lygon St, Suite 1, Level 3, Carlton, Victoria 3053, AU
Channeling Energy. Changing Lives.
Cancer is relentless. So are we. ARTBIO redefines cancer care by discovering and developing a new class of Alpha Radioligand Therapies (ARTs), powered by unique Pb-212 isotope technology and seamless supply. Our team works tirelessly to bring therapies that matter to patients who need them.
Offices: Kendall Sq, c/o Alexandria LaunchLabs B200, Suite 001, Cambridge, Massachusetts 02139, US · Gaustadalléen 21, Oslo Science Park, Oslo, 0349, NO · Aeschengraben 9, Basel, BS 4051, CH · 77 New Cavendish Street, The Harley Building, London, England W1W 6XB, GB · 62 Lygon St, Suite 1, Level 3, Carlton, Victoria 3053, AU
